(Met(O)35)-Amyloid β-Protein (1-40)

DRUG PEPTIDES

CAT No.# CS-AX-00008
Category Drug Peptides
CAS 178302-50-6
Stock Status
AVAILABLE ENQUIRE NOW View COA

(Available within 3-5 days)

Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing.
Molecular Weight 4345.87
Molecular Formula C194H295N53O59S
Purity: >98%
Synonyms: (α-aspartylalanyl-α-glutamylphenylalanylarginylhistidyl-α-aspartylserylglycyltyrosyl-α-glutamylvalylhistidylhistidylglutamyllysylleucylvalylphenylalanylphenylalanylalanyl-α-glutamyl-α-aspartylvalylglycylserylasparagyllysylglycylalanylisoleucylisoleucylglycylleucylmethionyloxy)valylglycylglycylvalylvaline
Shipping: Free Shipping for worldwide on order above 2000 USD
(Met(O)35)-Amyloid β-Protein (1-40) Worldwide Suppliers of (Met(O)35)-Amyloid β-Protein (1-40) Drug Peptides Clearsynth CS-AX-00008

Product rating: 9 (Met(O)35)-Amyloid β-Protein (1-40) based on 20 ratings

  1. Drug Peptides
  2. (Met(O)35)-Amyloid β-Protein (1-40)


PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Riluzole (1604337)
15. Pheniramine impurity B
16. Palbociclib N-Glucuronide
17. Carpropamid
18. Olmesartan N1-Trityl Impurity
19. 1-Octadecanethiol
20. H-Ser(Bzl)-OBzl . p-tosylate (E-3755.0005)


This page contains information about (Met(O)35)-Amyloid β-Protein (1-40) Cas 178302-50-6 and its Drug Peptides.

(Met(O)35)-Amyloid β-Protein (1-40) (Met(O)35)-Amyloid β-Protein (1-40) Worldwide Suppliers of (Met(O)35)-Amyloid β-Protein (1-40) Drug Peptides Clearsynth 178302-50-6

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."